000 01223 a2200337 4500
005 20250511222957.0
264 0 _c19900601
008 199006s 0 0 eng d
022 _a0887-6134
024 7 _a10.1002/bms.1200190316
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAli, M H
245 0 0 _aMetabolism studies of the antischistosomal drug praziquantel using tandem mass spectrometry: distribution of parent drug and ten metabolites obtained from control and schistosome-infected mouse urine.
_h[electronic resource]
260 _bBiomedical & environmental mass spectrometry
_cMar 1990
300 _a186-90 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aBiotransformation
650 0 4 _aFemale
650 0 4 _aHydroxylation
650 0 4 _aMale
650 0 4 _aMass Spectrometry
650 0 4 _aMice
650 0 4 _aPraziquantel
_xurine
650 0 4 _aSchistosomiasis mansoni
_xurine
700 1 _aAbramson, F P
700 1 _aFetterolf, D D
700 1 _aCohn, V H
773 0 _tBiomedical & environmental mass spectrometry
_gvol. 19
_gno. 3
_gp. 186-90
856 4 0 _uhttps://doi.org/10.1002/bms.1200190316
_zAvailable from publisher's website
999 _c2116159
_d2116159